211 related articles for article (PubMed ID: 16531332)
1. A quantitative exploration of surface antigen expression in common B-cell malignancies using flow cytometry.
Olejniczak SH; Stewart CC; Donohue K; Czuczman MS
Immunol Invest; 2006; 35(1):93-114. PubMed ID: 16531332
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
4. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry.
Echeverri C; Fisher S; King D; Craig FE
Am J Clin Pathol; 2002 Apr; 117(4):615-20. PubMed ID: 11939737
[TBL] [Abstract][Full Text] [Related]
6. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
7. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
8. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
9. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
10. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
Kingma DW; Imus P; Xie XY; Jasper G; Sorbara L; Stewart C; Stetler-Stevenson M
Cytometry; 2002 Oct; 50(5):243-8. PubMed ID: 12360573
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
[TBL] [Abstract][Full Text] [Related]
12. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].
Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J
Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727
[TBL] [Abstract][Full Text] [Related]
13. Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/kappa/lambda clonality test.
Peters RE; Janossy G; Ivory K; al-Ismail S; Mercolino T
Leukemia; 1994 Nov; 8(11):1864-70. PubMed ID: 7967732
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders.
McCarron KF; Hammel JP; Hsi ED
Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881
[TBL] [Abstract][Full Text] [Related]
15. Diminished expression of CD19 in B-cell lymphomas.
Yang W; Agrawal N; Patel J; Edinger A; Osei E; Thut D; Powers J; Meyerson H
Cytometry B Clin Cytom; 2005 Jan; 63(1):28-35. PubMed ID: 15624204
[TBL] [Abstract][Full Text] [Related]
16. [Quantitative flowcytometric analysis of B cell surface antigens in patients with autoimmune diseases].
Oooto Y; Ikemoto T; Nakagawa T; Shimizu A
Rinsho Byori; 1995 Apr; 43(4):381-4. PubMed ID: 7537832
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric expression of common antigens CD18/CD45 in blood from dogs with lymphoid malignancies: a semi-quantitative study.
Comazzi S; Gelain ME; Riondato F; Paltrinieri S
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):243-52. PubMed ID: 16698089
[TBL] [Abstract][Full Text] [Related]
19. Quantitative criteria for clonality in the diagnosis of B-cell non-Hodgkin's lymphoma by flow cytometry.
Geary WA; Frierson HF; Innes DJ; Normansell DE
Mod Pathol; 1993 Mar; 6(2):155-61. PubMed ID: 8483885
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltration.
Carulli G; Stacchini A; Marini A; Ciriello MM; Zucca A; Cannizzo E; Aliberti S; Demurtas A; Novero D; Calcagno L; Callegari T; Petrini M
Am J Clin Pathol; 2009 Aug; 132(2):186-90; quiz 306. PubMed ID: 19605812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]